NewsNow: Epilepsy news | Breaking News & Search 24/7
Read the latest Epilepsy headlines, all in one place, on NewsNow: the one-stop shop for news
Stay updated with breaking news from Presents Long Term Data. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Read the latest Epilepsy headlines, all in one place, on NewsNow: the one-stop shop for news
th Annual Meeting of the EBMT ZUG, Switzerland — 15 March, 2021— bluebird bio, Inc. (Nasdaq: BLUE) announced new data from the clinical development programme for its investigational elivaldogene autotemcel (eli-cel, Lenti-D™) gene therapy in patients with cerebral adrenoleukodystrophy (CALD), including updated results from the pivotal Phase 2/3 Starbeam study (ALD-102) and the long-term follow-up study LTF-304, as well as safety outcomes from the Phase 3 ALD-104 study. These data were presented today in an oral presentation during the Presidential Symposium at the 47 th Annual Meetin...